Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
Developing a chewing gum to reduce the incidence of Covid-19
A chewing gum impregnated with a plant-grown protein can serve as a “trap” for the SARS-CoV-2 virus, reducing viral load in the chewers saliva and potentially tamping down transmission.
A record-breaking year for innovation
With its highest number of patents issued, commercial agreements, corporate-sponsored research funding, and licensing revenue receipts in a single period, PCI experienced a landmark fiscal year.
Choosing the University of Pennsylvania for Its Excellence: As a Student, a Patient, and Employee
Carter Caldwell, the Director of the Penn Medicine Co-Investment Program, wrote a guest blog for Penn Medicine News on how the University has impacted his life as a student, a patient, and an employee
I-Corps graduate, Strella Biotechnology, featured in Washington Post story
A featured story on Katherine Sizov, founder of Strella Biotechnology, and how the company's sensors are reducing food waste and fighting climate change.
Penn launches $750M investment in science, engineering, and medicine
President Amy Gutmann has announced the launch of a $750 million investment.
Pennovation Works Celebrates Five Years
November 8, 2021 marked the fifth anniversary of Pennovation Works, Penn’s business incubator and laboratory space.
Celebrating five years of innovation, entrepreneurship, and creativity
Penn Today marks the anniversary of Pennovation Works with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
Success stories in gene therapy
Scientific American recently featured four stories on advancements in gene therapy.
Updated PCI Ventures Flagship Programs announced
PCI Ventures updated its flagship programs this past year that support University startups.
Interius BioTherapeutics Moves to Pennovation Lab
In October 2021, Interius BioTherapeutics (“Interius”) signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.